BCM
ACOR

Bridgeway Capital Management’s Acorda Therapeutics ACOR Stock Holding History

Bridgeway Capital Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,835
Closed -$45K – 1484
2023
Q1 		$45K Hold
3,835
– – ﹤0.01% 1317
2022
Q4 		$58.8K Sell
3,835
-1,250
-25% -$14.6K ﹤0.01% 1283
2022
Q3 		$30K Hold
5,085
– – ﹤0.01% 1376
2022
Q2 		$47K Sell
5,085
-7,120
-58% -$127K ﹤0.01% 1287
2022
Q1 		$393K Hold
12,205
– – 0.01% 1000
2021
Q4 		$583K Buy
12,205
+5,175
+74% +$357K 0.01% 938
2021
Q3 		$647K Buy
7,030
+1,950
+38% +$162K 0.01% 959
2021
Q2 		$485K Buy
5,080
+1,559
+44% +$136K 0.01% 1073
2021
Q1 		$343K Buy
3,521
+2,150
+157% +$264K 0.01% 1199
2020
Q4 		$114K Sell
1,371
-755
-36% -$69.4K ﹤0.01% 1261
2020
Q3 		$131K Sell
2,126
-750
-26% -$56.6K ﹤0.01% 1233
2020
Q2 		$254K Buy
2,876
+1,292
+82% +$137K 0.01% 1085
2020
Q1 		$177K Sell
1,584
-1,225
-44% -$241K ﹤0.01% 1090
2019
Q4 		$688K Buy
2,809
+1,167
+71% +$294K 0.01% 843
2019
Q3 		$565K Hold
1,642
– – 0.01% 909
2019
Q2 		$1.51M Sell
1,642
-166
-9% -$204K 0.02% 621
2019
Q1 		$2.88M Hold
1,808
– – 0.04% 395
2018
Q4 		$3.38M Buy
+1,808
New +$3.93M 0.04% 293

Other funds holding ACOR

DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Bridgeway Capital Management's ACOR Position: Q2 2023 in Review

Bridgeway Capital Management sold out of Acorda Therapeutics (ACOR) in Q2 2023, closing a stake of 3,835 shares — an estimated $45K sold.

Bridgeway Capital Management first reported a position in ACOR in Q4 2018 and held it in 18 quarters. The position peaked at $3.38M in Q4 2018. 15 funds tracked by Wall St. Rank hold ACOR as of Q2 2023.

  • Bridgeway Capital Management reported no remaining Acorda Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Bridgeway Capital Management sold 3,835 Acorda Therapeutics shares in Q2 2023, an estimated $45K.
  • Bridgeway Capital Management first reported a position in Acorda Therapeutics in Q4 2018 and held it in 18 quarters.
  • Bridgeway Capital Management's Acorda Therapeutics position peaked at $3.38M in Q4 2018.
  • 15 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2023.

Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.